Saturday December 30, 2006
IV Nimodipine

For intensivists who work in "neuro" units, it may be of interest to know that there are reports of using Nimodipine intravenously (IV) in patients who cannot tolerate oral route. But FDA has a strong warning again giving it intravenously or parenterally. It can cause serious adverse events, including death. Nimodipine is a calcium-channel blocker, which lowers blood pressure; and when given intravenously it may cause cardiovascular collapse. Ensure that nimodipine never administered intravenously as it is not safe.


Reference: click to read warning

Alert for Healthcare Professionals Nimodipine (marketed as Nimotop) - pdf file - fda.gov